AEON Biopharma, Inc. (AEON)
NYSEAMERICAN: AEON · Real-Time Price · USD
0.2930
+0.0378 (14.81%)
At close: Jul 31, 2026, 4:00 PM EDT
0.2878
-0.0052 (-1.77%)
Pre-market: Aug 3, 2026, 8:08 AM EDT
AEON Biopharma Market Cap
AEON Biopharma has a market cap or net worth of $7.71 million as of August 3, 2026. Its market cap has decreased by -7.21% in one year.
Market Cap
7.71M
Enterprise Value
4.09M
1-Year Change
-7.21%
Ranking
Category
Stock Price
$0.29
ChartMarket Cap Chart
Since April 12, 2021, AEON Biopharma's market cap has decreased from $63.66M to $7.71M, a decrease of -87.89%. That is a compound annual growth rate of -32.84%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 7.71M | -40.81% |
| Dec 31, 2025 | 13.02M | -39.67% |
| Dec 31, 2024 | 21.58M | -91.93% |
| Dec 29, 2023 | 267.55M | -80.82% |
| Dec 30, 2022 | 1.40B | 553.24% |
| Dec 30, 2021 | 213.58M | 235.51% |
| Apr 12, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lunai Bioworks | 8.80M |
| CNS Pharmaceuticals | 8.50M |
| Aspire Biopharma Holdings | 8.44M |
| Immuron | 8.25M |
| Niki BioSolutions | 8.04M |
| Aprea Therapeutics | 7.68M |
| Bolt Biotherapeutics | 7.67M |
| MetaVia | 7.33M |